Skip to main content

Table 3 Swedish universities Scales of Personality (SSP) raw scores (mean [standard deviation]) and 95% confidence interval (CI) of the difference between baseline and follow-up in patients with psychotic illness and non-psychotic controls

From: Correction to: Stability of personality traits over a five-year period in Swedish patients with schizophrenia spectrum disorder and nonpsychotic individuals: a study using the Swedish universities scales of personality

  

N

Somatic Trait Anxiety

Psychic Trait Anxiety

Stress Susceptibility

Baseline

Follow-up

CI

Baseline

Follow-up

CI

Baseline

Follow-up

CI

ALL

Patient

36

2.08 (0.48)

2.13 (0.53)

−0.25 – 0.15

2.45 (0.62)

2.36 (0.61)

−0.09 – 0.27

2.46 (0.55)

2.47 (0.53)

−0.19 – 0.16

Control

76

1.58 (0.46)

1.55 (0.45)

−0.06 – 0.12

1.66 (0.50)

1.48 (0.39)

0.11–0.26

1.87 (0.47)

1.82 (0.44)

−0.05 – 0.14

ALL

Men

75

1.68 (0.48)

1.71 (0.56)

−0.14 – 0.08

1.92 (0.68)

1.79 (0.66)

0.04–0.22

2.06 (0.61)

2.02 (0.58)

−0.06 – 0.14

Women

37

1.85 (0.58)

1.78 (0.53)

−0.08 – 0.21

1.90 (0.60)

1.70 (0.55)

0.07–0.34

2.04 (0.46)

2.05 (0.53)

−0.17 – 0.16

PATIENT

Men

28

2.05 (0.39)

2.19 (0.51)

−0.39 – 0.09

2.47 (0.60)

2.43 (0.52)

−0.17 – 0.24

2.48 (0.60)

2.52 (0.46)

−0.24 – 0.17

Women

8

2.21 (0.71)

1.93 (0.57)

0.02–0.55

2.38 (0.71)

2.09 (0.84)

−0.17 – 0.74

2.36 (0.38)

2.30 (0.76)

−0.40 – 0.51

CONTROL

Men

47

1.47 (0.39)

1.43 (0.36)

−0.06 – 0.14

1.60 (0.49)

1.41 (0.37)

0.10–0.28

1.81 (0.47)

1.72 (0.41)

−0.02 – 0.20

Women

29

1.75 (0.51)

1.74 (0.52)

−0.16 – 0.18

1.77 (0.51)

1.59 (0.40)

0.04–0.33

1.96 (0.45)

1.98 (0.44)

−0.21 – 0.17

  

Lack of Assertiveness

Impulsiveness

Adventure Seeking

Baseline

Follow-up

CI

Baseline

Follow-up

CI

Baseline

Follow-up

CI

ALL

Patient

2.50 (0.64)

2.43 (0.62)

−0.13 – 0.28

2.33 (0.52)

2.25 (0.51)

−0.07 – 0.23

2.50 (0.58)

2.38 (0.61)

−0.04 – 0.29

Control

1.91 (0.40)

1.87 (0.43)

−0.04 – 0.11

2.30 (0.46)

2.19 (0.47)

0.02–0.20

2.53 (0.52)

2.39 (0.51)

0.07–0.22

ALL

Men

2.12 (0.58)

2.07 (0.61)

−0.06 – 0.16

2.23 (0.47)

2.15 (0.47)

−0.01 – 0.17

2.57 (0.58)

2.42 (0.56)

0.06–0.25

Women

2.06 (0.54)

2.02 (0.44)

− 0.07 – 0.15

2.48 (0.45)

2.34 (0.49)

0.01–0.28

2.42 (0.43)

2.33 (0.50)

− 0.01 – 0.21

PATIENT

Men

2.55 (0.59)

2.48 (0.63)

−0.18 – 0.33

2.28 (0.51)

2.21 (0.52)

−0.12 – 0.24

2.52 (0.62)

2.34 (0.65)

−0.02 – 0.38

Women

2.34 (0.83)

2.27 (0.59)

−0.21 – 0.35

2.52 (0.51)

2.38 (0.48)

−0.22 – 0.49

2.46 (0.39)

2.54 (0.46)

−0.33 – 0.19

CONTROL

Men

1.86 (0.40)

1.83 (0.45)

−0.06 – 0.13

2.19 (0.44)

2.11 (0.44)

−0.02 – 0.20

2.61 (0.55)

2.47 (0.51)

0.04–0.24

Women

1.99 (0.41)

1.95 (0.37)

−0.09 – 0.16

2.47 (0.44)

2.33 (0.50)

−0.00 – 0.30

2.41 (0.44)

2.27 (0.50)

0.02–0.27

  

Detachment

Social Desirability

Embitterment

Baseline

Follow-up

CI

Baseline

Follow-up

CI

Baseline

Follow-up

CI

ALL

Patient

2.33 (0.63)

2.31 (0.52)

−0.14 – 0.17

2.77 (0.53)

2.83 (0.45)

−0.24 – 0.13

2.23 (0.50)

2.22 (0.55)

−0.15 – 0.17

Control

1.90 (0.43)

1.85 (0.43)

−0.02 – 0.12

2.83 (0.37)

2.92 (0.35)

−0.15 - -0.03

1.60 (0.41)

1.47 (0.40)

0.05–0.20

ALL

Men

2.16 (0.54)

2.13 (0.49)

−0.05 – 0.12

2.80 (0.43)

2.88 (0.39)

−0.16 – 0.00

1.82 (0.52)

1.72 (0.59)

0.01–0.20

Women

1.78 (0.45)

1.74 (0.42)

−0.09 – 0.18

2.82 (0.42)

2.90 (0.38)

−0.21 – 0.06

1.75 (0.56)

1.69 (0.54)

−0.06 – 0.18

PATIENT

Men

2.41 (0.65)

2.39 (0.50)

−0.14 – 0.20

2.82 (0.56)

2.80 (0.46)

−0.18 – 0.21

2.23 (0.44)

2.23 (0.57)

−0.20 – 0.20

Women

2.04 (0.52)

2.05 (0.53)

−0.51 – 0.48

2.61 (0.42)

2.91 (0.44)

−0.87 – 0.26

2.23 (0.69)

2.17 (0.51)

−0.22 – 0.34

CONTROL

Men

2.02 (0.41)

1.97 (0.42)

−0.05 – 0.13

2.79 (0.34)

2.93 (0.34)

−0.21 - − 0.07

1.58 (0.39)

1.42 (0.34)

0.08–0.25

Women

1.71 (0.41)

1.65 (0.35)

-0.07 – 0.20

2.88 (0.41)

2.90 (0.36)

−0.12 – 0.09

1.62 (0.45)

1.56 (0.47)

−0.08 – 0.20

  

Trait Irritability

Mistrust

  

Baseline

Follow-up

CI

Baseline

Follow-up

CI

ALL

Patient

2.35 (0.57)

2.13 (0.57)

0.03–0.40

2.26 (0.58)

2.26 (0.52)

− 0.13 – 0.15

  

Control

2.21 (0.48)

2.03 (0.49)

0.09–0.26

1.75 (0.50)

1.60 (0.47)

0.06–0.24

  

ALL

Men

2.26 (0.49)

2.04 (0.53)

0.12–0.31

1.97 (0.56)

1.86 (0.57)

0.02–0.21

  

Women

2.24 (0.55)

2.11 (0.50)

−0.03 – 0.29

1.81 (0.59)

1.72 (0.58)

−0.03 – 0.21

  

PATIENT

Men

2.36 (0.56)

2.16 (0.53)

0.01–0.38

2.28 (0.58)

2.25 (0.53)

−0.14 – 0.21

  

Women

2.32 (0.66)

2.04 (0.74)

−0.37 – 0.94

2.20 (0.62)

2.29 (0.55)

−0.24 – 0.07

  

CONTROL

Men

2.20 (0.45)

1.97 (0.51)

0.11–0.34

1.79 (0.47)

1.62 (0.47)

0.05–0.28

  

Women

2.22 (0.53)

2.13 (0.43)

−0.05 – 0.22

1.70 (0.54)

1.56 (0.49)

−0.01 -0.29

  
  

Verbal Trait Aggression

Physical Trait Aggression

  

Baseline

Follow-up

CI

Baseline

Follow-up

CI

ALL

Patient

2.01 (0.64)

2.00 (0.55)

−0.19 – 0.20

1.71 (0.57)

1.84 (0.60)

−0.31 – 0.07

  

Control

2.15 (0.47)

1.96 (0.46)

0.10–0.28

1.93 (0.57)

1.67 (0.54)

0.17–0.35

  

ALL

Men

2.12 (0.53)

2.02 (0.52)

−0.01 – 0.21

1.92 (0.60)

1.81 (0.59)

0.00–0.23

  

Women

2.07 (0.55)

1.88 (0.43)

0.04–0.33

1.73 (0.53)

1.55 (0.46)

0.01–0.33

  

PATIENT

Men

2.03 (0.62)

2.07 (0.58)

−0.26 – 0.18

1.76 (0.59)

1.86 (0.66)

−0.33 – 0.13

  

Women

1.95 (0.74)

1.79 (0.38)

−0.37 – 0.69

1.54 (0.47)

1.74 (0.39)

−0.57 – 0.16

  

CONTROL

Men

2.18 (0.46)

2.00 (0.48)

0.07–0.31

2.02 (0.58)

1.78 (0.55)

0.14–0.35

  

Women

2.10 (0.50)

1.91 (0.44)

0.04–0.34

1.78 (0.54)

1.50 (0.47)

0.11–0.44

  
Back to article page

BMC Psychiatry

ISSN: 1471-244X

Contact us